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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
Tuberculosis and COVID-19: COVID-19 considerations for TB care 
WHO | 4 April 2020 | Information note 
https://www.who.int/tb/COVID_19considerations_tuberculosis_services.pdf 
This note is intended to assist national TB programmes and health personnel to maintain continuity 
of essential services for people affected with TB during the COVID-19 pandemic. Includes 
information on risk of COVID-19 infection, illness and death in people with TB; protection of staff 
working in TB laboratories, healthcare facilities and community health workers; protection of people 
seeking TB care; testing for TB and COVID-19; and TB treatment in those with COVID-19. 
Masks and handwashing vs. physical distancing: do we really have evidence-based 
answers for policymakers in resource-limited settings? 
Saleh, A. & Cash R.A. | Center for Global Development | 3 April 2020 
https://www.cgdev.org/blog/masks-handwashing-vs-physical-distancing-do-we-really-have-
evidence-based-answers 
Leaders from LMICs are increasingly sceptical of mimicking policies that may have worked in 
China, South Korea, Germany and elsewhere because of radical differences in demography; 
endemic conditions that affect the immune system (malnutrition, anaemia, malaria, HIV/AIDS and 
TB) that are likely to increase the severity of COVID-19; health system capacity which is often 
weak, already stretched experiencing the double burden of disease and has extremely low critical 
care capacity; and cultural context where social cohesion and social gatherings are greatly 
important. The strategic approach should instead focus on containment and aggressive preventive 
measures engaging with the community, health leadership, and involvement of youth and religious 
leaders. Epidemiological models need to take into account the possibility that physical distancing 
policies could fuel widespread community transmission rather than contain COVID-19 as has been 
seen as urban migrants flee cities to avoid paying rent and be with their family during the crisis; 
that physical distancing policies will be difficult to follow in overcrowded informal slums which lack 
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sufficient access to water and sanitation facilities. Consideration should also be given to 
emergency provision of food and cash to accompany forced loss of income. More emphasis can 
be placed on handwashing and good respiratory hygiene e.g. masks can be produced at scale. 
Disability considerations during the COVID-19 outbreak 
WHO | 26 March 2020 | Recommended actions 
https://www.who.int/who-documents-detail/disability-considerations-during-the-covid-19-outbreak 
During the COVID-19 outbreak people with disability must be able to access the healthcare 
services and public health information that they require. A number of challenges are listed that 
may put people with disability at greater risk of contracting COVID-19. Actions are proposed for 
the following groups – people with disability and their household; governments; healthcare 
workers; disability service providers; and the community. 
Shared responsibility, global solidarity: responding to the socio-economic impacts of 
COVID-19 
UN | March 2020 | Report 
https://unsdg.un.org/sites/default/files/2020-03/SG-Report-Socio-Economic-Impact-of-
Covid19.pdf 
A new UN report calls for shared responsibility and global solidarity on COVID-19 and for action 
in three specific areas (1) suppressing the transmission of the virus to control the pandemic; (2) 
safeguarding people’s lives and their livelihoods; and (3) learning from this human crisis to build 
back better. 
COVID-19: A Gender Lens Protecting sexual and reproductive health and rights, and 
promoting gender equality 
UNFPA | March 2020 |Technical Brief 
https://www.unfpa.org/sites/default/files/resource-pdf/COVID-
19_A_Gender_Lens_Guidance_Note.pdf 
Includes key messages including how women and men are impacted differently and 
recommendations. 
Three UK national COVID-19 treatment trials 
Platform Randomised trial of INterventions against COVID-19 In older peoPLE 
(PRINCIPLE) Trial 
University of Oxford | Clinical trial 
https://www.phctrials.ox.ac.uk/principle-trial 
This trial aims to evaluate if selected treatments in addition to usual care compared to usual care 
alone given to those at higher risk of becoming more ill when they are infected with COVID-19 can 
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help reduce the need for hospitalisation and the length of stay required, help people recover 
quicker and with fewer complications. Enrolment is through GP surgeries registered in the trial and 
is open to those aged 50 to 64 and have a listed underlying condition and to anyone aged 65 or 
over both groups with symptoms experienced for fewer than eight days and likely to be caused by 
a COVID-19 infection. 
Randomised Evaluation of COVID-19 Therapy (RECOVERY) clinical trial 
University of Oxford | Clinical trial 
https://www.recoverytrial.net 
This clinical trial will invite every adult patient hospitalised into the NHS with confirmed COVID-19 
to enter the trial and if they accept be allocated to standard care or standard care plus one of the 
new therapeutic options (lopinavir-ritonavir (commonly used to treat HIV), low-dose 
dexamethasone (a type of steroid, which is used in a range of conditions typically to reduce 
inflammation), hydroxychloroquine (related to an anti-malarial drug). The trial has currently 
prioritised expert recommended drugs but has the flexibility to add new recommendations or new 
drugs as they become available. Almost 1000 patients from 132 different hospitals have been 
already recruited in 15 days. 
Randomised, Embedded, Multifactorial, Adaptive Platform Trial for Community-Acquired 
Pneumonia (REMAP-CAP) 
Imperial College London | Clinical trial 
https://www.remapcap.org/coronavirus 
Part of 50 sites across the world, this trial will evaluate treatment of patients with severe CAP 
resulting from coronavirus. Currently these interventions are prolonged macrolide therapy (as a 
modulator of immune function); alternative corticosteroid strategies; lopinavir/ritonavir antiviral 
therapy; and immune modulation therapy. 
 
Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
Johns Hopkins University COVID-19 dashboard in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467
b48e9ecf6 
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Vaccine Centre, LSHTM  
https://vac-lshtm.shinyapps.io/ncov_tracker/ 
This site complements the WHO and Johns Hopkins University COVID-19 dashboards by 
including the timeline functions, the ability to overlay past outbreaks, and an emphasis on 
normalised counts (per 100,000 individuals). 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
Africa 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4bb14 
Online learning  
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
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Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
Resource Hubs 
Reliefweb COVID-19 
https://reliefweb.int/topics/covid-19 
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Coronavirus global health emergency 
https://www.un.org/coronavirus 
Norwegian Institute of Public Health: Live map of COVID-19 evidence 
https://www.fhi.no/en/qk/systematic-reviews-hta/map/ 
Overview of scientific publications on COVID-19 categorised into subgroups to provide quick 
access to specific topic-relevant publications to help decision makers and research navigate the 
research and help identify research gaps.  
Vaccine Centre at LSHTM: COVID-19 vaccine development pipeline tracker 
https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/ 
COVID-19 Research Project Tracker by UKCDR & GloPID-R 
https://www.ukcdr.org.uk/funding-landscape/covid-19-research-project-tracker/ 
A live database of funded research projects across the world related to COVID-19 mapped against 
the priorities identified in the WHO Coordination Global Research Roadmap: 2019 Novel 
Coronavirus. 
WHO Q&A on COVID-19 
https://www.who.int/news-room/q-a-detail/q-a-coronaviruses 
Note that this resource includes Q&A on COVID-19; COVID-19, pregnancy, childbirth and 
breastfeeding; COVID-19, HIV and antiretrovirals; similarities and differences COVID-19 and 
influenza; mass gatherings and COVID-19; IPC for healthcare workers; COVID-19 and food and 
agriculture; smoking and COVID-19; malaria and COVID-19. 
COVID-19: Resources and research on epidemics and pandemics 
https://steps-centre.org/covid-19-coronavirus-resources-research-epidemics-pandemics/ 
Stop TB Partnership TB and COVID-19 
http://www.stoptb.org/covid19.asp 
EPI-WIN: WHO information network for epidemics: COVID-19 public health emergency 
https://www.who.int/teams/risk-communication 
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COVID-19: Research ethics 
https://ethicsresource.ringsgenderresearch.org/covid-19-resources/ 
LSTM: COVID-19 
https://www.lstmed.ac.uk/covid-19 
LSHTM: COVID-19 
https://www.lshtm.ac.uk/research/research-action/covid-19 
International Disability Alliance: COVID 19 and the disability movement 
http://www.internationaldisabilityalliance.org/content/covid-19-and-disability-movement 
Africa Centres for Disease Control and Prevention (Africa CDC) 
https://africacdc.org/covid-19/ 
UNICEF: Latest news and updates on coronavirus disease 2019 (COVID-19) 
https://www.unicef.org/coronavirus/covid-19 
Coronavirus: the science explained 
https://coronavirusexplained.ukri.org/en/ 
Social Science in Humanitarian Action: Updates on the novel COVID-19 outbreak 
https://www.socialscienceinaction.org/update-novel-covid-19-outbreak/ 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
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Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-
coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.htmlThe Global Health Network Coronavirus 
outbreak knowledge hub 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campaign=
DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
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Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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